Markets:

Overview

News

Currencies

International

Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

29.39 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Quidel Corp (QDEL) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

QDEL earnings call for the period ending October 4, 2021.

Via The Motley Fool

Topics Earnings

Quidel Reports Third Quarter 2021 Financial Results

November 04, 2021

From Quidel Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation

November 02, 2021

Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation

Via News Direct

Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation

November 02, 2021

From Quidel Corporation

Via Business Wire

Quidel to Hold Fiscal Third Quarter 2021 Financial Results Conference Call on November 4th, 2021

October 20, 2021

From Quidel Corporation

Via Business Wire

Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead

October 20, 2021

FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using...

Via FinancialNewsMedia

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Pediatric Lyme Disease—‘An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21

October 18, 2021

From Quidel Corporation

Via Business Wire

Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21

October 18, 2021

Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21

Via News Direct

Quidel Blows Past Estimates for Q3 Revenue ↗

October 14, 2021

COVID-19 testing volumes are up again.

Via The Motley Fool

Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected ↗

October 08, 2021

Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:...

Via Benzinga

After the Jobs Report, Investors are Looking at The Fed for Tapering Signals ↗

October 08, 2021

Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000...

Via Benzinga

Topics Economy

A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data ↗

October 08, 2021

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade ahead of the all-important jobs report for the month of September. Analysts expect nonfarm...

Via Benzinga

5 Stocks To Watch For October 8, 2021 ↗

October 08, 2021

Some of the stocks that may grab investor focus today are: At its annual shareholder meeting, Tesla Inc’s (NASDAQ: TSLA) CEO Elon Musk announced plans to move its...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 07, 2021

Gainers Vaxart (NASDAQ:VXRT) shares incr...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021

October 07, 2021

From Quidel Corporation

Via Business Wire

Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters ↗

October 06, 2021

In recent weeks, an increase in demand for COVID-19 tests from U.S. employers has deepened the shortage of rapid tests and is driving up testing programs costs. What Happened: The...

Via Benzinga

2 Growth Stocks to Buy if You're Worried COVID Is Here to Stay ↗

October 02, 2021

These could be good hedges to help offset the pandemic-related risks.

Via The Motley Fool

Biotech Playbook Revisited As Technicals Weaken ↗

September 27, 2021

Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still...

Via Talk Markets

FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations ↗

September 24, 2021

The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19...

Via Benzinga

Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

September 14, 2021

Via FinancialNewsMedia

Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market ↗

September 09, 2021

Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.

Via Talk Markets

Why Shares of Quidel Surged 10% This Week ↗

September 02, 2021

Demand for its COVID tests are rising with cases.

Via The Motley Fool

Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy ↗

September 02, 2021

Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Quidel to Bring QuickVue® At-Home OTC COVID-19 Tests To CVS Pharmacy

September 01, 2021

From Quidel Corporation

Via Business Wire

10 Stocks For You To Review ↗

September 01, 2021

Here are 10 stocks you asked me to analyze. Some are attractive, some are dangerously overvalued and all of them offer teaching points.

Via Talk Markets

Return on Capital Employed Insights for Quidel ↗

August 27, 2021

Pulled from Benzinga Pro data Quidel (NASDAQ:QDEL) posted Q2 earnings of $24.33 million, an increase from Q1 of 89.18%. Sales dropped to $176.61 million, a 52.95% decrease between...

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

All News about QuidelOrtho Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today